XML 138 R121.htm IDEA: XBRL DOCUMENT v3.20.2
Share-Based Compensation (Narrative) (Details) - USD ($)
$ / shares in Units, $ in Millions
12 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2018
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Shares available for future grant 4,341,614    
Closing stock price (in dollars per share) $ 297.86    
Cash received from option exercises $ 34.1 $ 68.1 $ 76.2
Total tax benefit realized from stock option exercises 15.4    
Excess tax benefit from stock option exercises $ 14.2    
Deferred Stock Units      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Number of units/shares granted 203,000    
Weighted-average grant date fair value (in dollars per share) $ 252.53    
Cash payments made for deferred stock units $ 4.8 1.9 2.2
Unrecognized compensation costs $ 52.7    
Unrecognized compensation costs, period for recognition, years 2 years    
Fair value of deferred stock units paid $ 65.4 $ 19.2 $ 38.5
Deferred Stock Units | Minimum      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Vesting or deferral period 2 years    
Deferred Stock Units | Maximum      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Vesting or deferral period 5 years    
Director Deferred Stock Units | Maximum      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Period after service in which to elect payment 10 years    
Market-Based Deferred Stock Unit      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Vesting or deferral period 3 years    
Number of units/shares granted 80,215 114,929 105,268
Weighted-average grant date fair value (in dollars per share) $ 275.19 $ 229.61 $ 202.50
Time-Based Deferred Stock Unit      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Number of units/shares granted 123,448 169,666 143,379
Weighted-average grant date fair value (in dollars per share) $ 230.92 $ 168.68 $ 162.11
Stock Options      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Vesting or deferral period 3 years    
Exercisable period from grant date 10 years    
Weighted average remaining contractual terms, outstanding 2 years 8 months 12 days    
Weighted average remaining contractual terms, exercisable 2 years 8 months 12 days    
Aggregated intrinsic value, outstanding $ 189.0    
Aggregated intrinsic value, exercisable 189.0    
Intrinsic value of stock options exercised 65.7 $ 87.2 $ 90.4
Cash received from option exercises 34.1    
Restricted Stock      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Unrecognized compensation costs 0.0    
Fair value of vested restricted stock $ 6.1 $ 2.6 $ 2.2
Restricted Stock | Minimum      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Vesting or deferral period 1 year    
Restricted Stock | Maximum      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Vesting or deferral period 4 years